Announcement of Approval of OTP Accrediting Organizations

Center for Substance Abuse Treatment

December 4, 2001

Dear Opioid Treatment Program Sponsor:

This letter is to apprize you of significant developments affecting opioid treatment programs. On November 30, the Substance Abuse and Mental Health Services Administration (SAMHSA) announced the approval of four accreditation bodies (enclosed) under the new opioid treatment program regulations (42 CFR Part 8). The four accreditation bodies are:

Commission on Accreditation of Rehabilitation Facilities (CARF)

Joint Commission on Accreditation of Healthcare Organizations (JCAHO)

Council on Accreditation for Children and Family Services (COA)

Washington State Department of Social and Health Services, Division of Alcohol and Substance Abuse

We have enclosed additional contact information (see Fact Sheet) about these approved accreditation bodies.

You may recall, as a condition for “transitional certification” under SAMHSAs new regulation (42 CFR 8.11(d)), each OTP agreed to apply to an approved accreditation body within 90 days from the date SAMHSA approves accreditation bodies under the rule. Therefore, OTPs with transitional certification must apply to one of the above accreditation bodies by March 4, 2002. OTPs that have received “provisional certification” must achieve accreditation within one year of their provisional certification date (see 42 CFR 8.11(e)).

CSAT has received questions (enclosed) from OTPs that are presently accredited by one of the above approved accreditation bodies. These OTPs have asked about the need to have an accreditation survey conducted at this time. As noted in the preamble to the final rule (66 FR 4086, January 17, 2001), SAMHSA will consider the issue on a case-by-case basis. OTPs that believe they have current accreditation status that involve substantial compliance with the Federal opioid treatment standards under 42 CFR 8.12, should submit supporting documentation to that effect to SAMHSA at the following address: Center for Substance Abuse Treatment (OPAT), 1 Choke Cherry Road, Room 2-1075, Rockville, MD 20857

The preamble to the final rule also discussed SAMHSAs intention to reduce the economic burden associated with accreditation costs. Accordingly, on October 23, SAMHSA issued a Guidance for Applicants (GFA) to permit approved accreditation organizations to apply for and obtain grants to reduce accreditation inspection and training costs to OTPs.

Thank you for your cooperation in this important public health initiative.

Sincerely,

H. Westley Clark, M.D., J.D., M.P.H., CAS, FASAM

Director

Center for Substance Abuse Treatment

Enclosures

Similar Posts

  • Methadone Maintenance and Patient Self-Advocacy by Arlene S. Ford

    Admin 06/19/2022

    Education Series Number 1 March 1991 Arlene Ford helped to start one of the first methadone advocacy groups at Nassau County Medical Center. This article was written for the COMPA Newsletter for distribution at the National Methadone Conference. Methadone has allowed me to salvage my life. In May of 1988, following a fourth relapse, my…

  • New Federal Regulations Issued to Improve Methadone Treatment

    Admin 04/02/2022

    SAMHSA Press Release January 17, 2001 New federal regulations were issued today to improve the quality and oversight of substance abuse treatment programs that use methadone and other medication to treat heroin and similar addictions. The regulations create a new accreditation program managed by the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for…

  • National Alliance of Methadone Advocates

    Admin 03/13/2023

    Membership Application Please complete and send to: National Alliance of Methadone Advocates 435 Second Avenue New York, NY, 10010 Name: Mr / Ms _______________________________________________________________________ Organization: _____________________________________ Title: ______________________________ Address: ____________________________________________________________________________ City: ___________________________________________________ State: ______________________ Zip Code (Postal Code): ____________________ Country: ____________________________________ Telephone: ______________________________________ Circle One: Day Eve Telephone: ______________________________________ Circle One: Day Eve Fax: ________________________________…

  • 3237 North Dousman Milwaukee, WI 53212

    Admin 03/10/2021

    Wisconsin Chapter of the National Alliance of Methadone Advocates 3237 North Dousman Milwaukee, WI 53212 President Greg Keller Mission Statement WI NAMA believes in the same Mission and goals as NAMA. Since its beginning over 25 years ago, methadone maintenance has been the most popular treatment for narcotic addiction. Many times over the years methadone…

  • What Is NAMA Recovery?

    Admin 03/14/2023

    The National Alliance for Medication Assisted Recovery (NAMA-R) is an organization of medication assisted treatment (MAT) patients, healthcare professionals, friends, and associates working together for greater public understanding and acceptance of MAT. Promotingquality MAT as the most effective modality for the treatment of opiate dependence. NAMA-R’s Goals To eliminate discrimination toward MAT patients To create…

  • Take Home Regulation Page 4098

    Admin 05/06/2021

    Page 4098 Federal Register Vol. 66, No. 11 / Wednesday, January 17, 2001 / Rules and Regulations (i) Unsupervised or “take-home” use. To limit the potential for diversion of opioid agonist treatment medications to the illicit market, opioid agonist treatment medications dispensed to patients for unsupervised use shall be subject to the following requirements. (1)…